Meetings

2018 Asian Pacific Congress of Nephrology – Beijing 27-31 March 2018 (9/4/2017)

APCN 2018 Website

On behalf of the Asian Pacific Society of Nephrology (APSN), and the Chinese Society of Nephrology, Chinese Medical Association, we invite submissions from those interested in presenting oral papers and posters at the Asian Pacific Congress of Nephrology 2018.

Closing date for abstracts is 15 October 2017

APCN 2018 Website

ANZSN/APCN 2016 Perth Australia (10/29/2016)

ANZSN/APCN 2016

The 15th Asian Pacific Congress of Nephrology & 52nd Australian and New Zealand Society of Nephrology Annual Scientific Meeting was held at the Perth Concention and Exhibition Centre, Western Australia, on 17-21 September 2016.

Photos and presentations (as video) are available below.

« 1 of 2 »

Presentations

Click on the title to view video of presentation.

Sep 18 – Seminar 1 Aetiology Pathogenesis
Prof Jonathan Hodgson – Vascular Health Benefits of Vasoactive Components of Plant Foods
A/Prof. Reiko Inagi – Renal Cellular Metabolism and Oxidative Stress
Prof. Hyug Moo Kwon – Association of the TonEBP Gene and Metabolic Diseases

Sep 18 – Seminar 2 – Transplantation
Prof. Kazunari Tanabe – ABO-Incompatible Kidney Transplantation – The Japanese Experience and Long-Term Outcomes
Prof. Philip O’Connell – Molecular Diagnostics, Biomarkers and Immune Monitoring in Transplantation

Sep 18 – KDIGO Hypertension Guideline Symposium
Dr Allan Collins – Reducing Global Burden of CKD and CVD: Devising Effective Public Health Messages and Policies for Blood Pressure Management
Prof. Vlado Perkovic – New Data for an Old Treatment – BP Lowering in 2016
Hypertension Q&A

Sep 18 – KHACARI Symposium on ADPKD Guidelines
Dr. Vincent Lee – Management of ICAs in ADPKD
Dr. Andrew Mallett – Pharmacological Management of ADPKD

Sep 18 – Seminar 3 – Challenges In Managing CKD AKI
Prof. Tazeen Jafar – Overcoming Health Systems Challenges in Managing CKD in the Community

Sep 18 – APSN Young Investigator – Basic
Dr Yosuke Hirakawa – Determination of urinary oxygen tension by phosphorescence lifetime measurement
Mr. Brijesh Yadav – IS HIGHER TH17 FREQUENCY CAUSES CHRONIC CALCINEURIN INHIBITOR TOXICITY IN RENAL ALLOGRAFT RECIPIENTS?
Miss Wenjuan Wang – HYDROGEN SULFIDE MEDIATES THE PROTECTION OF DIETARY RESTRICTION AGAINST RENAL SENESCENCE IN AGED F344 RATS

Sep 18 – Seminar 4 – Dialysis
Prof. Mai-Szu Wu – Initiation of Dialysis and Choice of Dialysis Modality
Prof. Robert Walker – Dialysis Outcomes in the Elderly, What is Important?
Dr. Katherine Bristowe – End of Life Planning in Dialysis

Sep 18 – Seminar 5 – CKD AKI
Dr. Kunitoshi Iseki – Haematuria Should be Included as a CKD Risk Factor

Sep 19 – CME Nephrology Update
Dr. Giovanni Strippoli – Challenges in Improving CV Outcomes in ESKD

Sep 19 – Seminar 6 – Transplantation
Dr. Jeremy Chapman – Global Initiatives in Biovigilance and Surveillance: Preventing Disease and Emerging Risks in Transplantation
Daniel Chan – Update on Hepatitis B Infection and Kidney Transplantation
Prof. Sang-Oh Lee – Living Donor and Recipient Screening for Latent Tuberculosis Infection

Sep 19 – Seminar 7 – CKD AKI
A/Prof. Kamal Sud – Managing AKI Survivors to Reduce Future CKD Burden

Sep 19 – Plenary
Prof. Ravi Thadhani – Pre-eclampsia: From Science to Medicine

Sep 19 – KDIGO CKD MBD Symposium
Dr Markus Ketteler – New Guidelines on CKD-MBD – Update on Calcium, Phosphorus and sHPT
A/Prof. Nigel Toussaint – New Guidelines on CKDMBD – Update on Bone Quality and Vitamin D
Dr Hirotaka Komaba – Medical and Surgical Management of Secondary Hyperparathyroidism: What can we Learn from Regional Variation?

Sep 19 – Seminar 8 – Dialysis
Prof. Philip Li – The Role of Bioimpedence Spectroscopy in Fluid Management of PD Patients
Prof. Adrian Liew – Glucose Sparing Strategies: Is the Evidence Strong Enough to Justify the Cost?
Dr. David Johnson – Management of PD Peritonitis: What Evidence do we Need?

Sep 19 – APSN Young Investigator Award
Dr. Ashok Yadav – CHOLECALCIFEROL SUPPLEMENTATION AND VASCULAR FUNCTION IN NON-DIABETIC CHRONIC KIDNEY DISEASE: A RANDOMISED, DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL
MD, PhD Akihiro Tsuda – GLOMERULAR HYPERFILTRATION AND INCREASED EFFERENT ARTERIOLAR RESISTANCE ARE PRESENT IN SUBJECTS WITH IMPAIRED GLUCOSE TOLERANCE
Dr. Yuta Matsukuma – GERIATRIC NUTRITIONAL RISK INDEX IS STRONGLY ASSOCIATED WITH INFECTION-RELATED MORTALITY IN HEMODIALYSIS PATIENTS: THE Q-COHORT STUDY
Dr Pahnwat T. Taweesedt – Pulmonary Hypertension in Hospitalized End-Stage-Renal Disease Patients

Sep 19 – Seminar 9 – Aetiology Pathogenesis
A/Prof. Chrishan Samuel – Mediators of Fibrosis in Chronic Kidney Disease
Prof. Sydney Tang – Toll-Like Receptor in Diabetic Nephropathy

Sep 19 – AKTN Session
Lai Seong Hooi – Australia – Malaysia Collaboration and FAVOURED Study
Dr. Matthew Roberts – BLOCADE Trial Results
Dr. Allison Tong – Composing a New Song for Nephrology
Prof. Vlado Perkovic – Opportunities in Pragmatic Trials

Sep 20 – CME Nephrology Update
Prof. Ravi Thadhani – Pregnancy and Kidney Disease: A Review

Sep 20 – Seminar 10 – CKD AKI
Dr. Giovanni Strippoli – Efficacy and Safety of Blood Pressure-Lowering Agents in Adults with Diabetes and CKD
Prof. Ravi Thadhani – Vitamin D: The More we Know, the Less we Know
Prof. Markus Schlaich – The Role of the Sympathetic Nervous System in Blood Pressure Regulation in CKD

Sep 20 – Seminar 11 – Transplantation
Ms Jenny Koo – Development of Organ Donation Initiatives in Hong Kong
Prof. Po-Chang Lee – Promoting Organ Donation in Taiwan – Difficulties and Innovations

Sep 20 – Hyperkalaemia
Prof. Masaomi Nangaku – Epidemiology of Hyperkalemia: Who is at Risk?
Prof. Vlado Perkovic – The Clinical Impact of Hyperkalemia
Q&A Session

Sep 20 – New Considerations in Delivering Home Haemodialysis
Dr Mike Copland – Home Haemodialysis Therapy Comparisons between Conventional Delivery Systems and NxStage
Dr. Shyam Dheda – The Use of NxStage to Facilitate Home Haemodialysis in Far North Queensland

Sep 20 – Plenary
Dr. Peter Doherty – The Killer Defence

Sep 20 – Seminar 12 – Haemodialysis
Dr. Colin Hutchison – High Cut-Off Dialysis for End Stage Renal Disease

Sep 20 – ANZDATA
Dr. Samuel Chan – Association of Socio-Economic Position with Technique Failure and Mortality in Australian Non-Indigenous Peritoneal Dialysis Patients
Dr. Philip Clayton – Research Developments in the Registry

Sep 20 – Seminar 13 – CKDAKI
A/Prof. Karen Moritz – Maternal Influence on Adult Outcomes
Prof. Masaomi Nangaku – Epigenetics of Renal Disease

Sep 20 – APSN Registries
Professor Dong-Chan Jin – Lessons from 30 Years’ Data, Korean ESRD Registry: 1985-2015
Prof. Chih-Cheng Hsu – CKD Prevention in Taiwan: Achievements and Challenges

Sep 21 – Seminar 14 – Transplantation
Prof. Sharon Ricardo – The Future of Stem Cells in Transplantation
Dr. Natasha Rogers – The Spectrum of Dendritic Cells and the Promise of Immunotherapy in Transplantation
Dr. Karen Dwyer – Ischaemia Reperfusion Injury in Kidney Allografts – Mechanisms and Opportunity for Intervention

Sep 21 – Seminar 15 – Dialysis
Prof. Sang Kyung Jo – CRRT in Critically Ill AKI Patients
Prof. Kent Doi – Indication of Renal Replacement Therapy for AKI
Prof. Ranistha Ratanarat – Prolonged Intermittent Renal Replacement Therapy in AKI

Sep 21 – Closing Plenary
Dr. Katherine Bristowe – Supporting the Needs of People with End Stage Kidney Disease: Lessons from Recent Research

Closing Ceremony


 

 

Past APCN Congresses

1979 Foundation Meeting – Tokyo, Japan

1983 2nd Congress APSN – Melbourne, Australia

1986 3rd Congress APSN – Singapore

1990 4th Congress APSN – Beijing, China

1992 5th Congress APSN – Delhi, India

1995 6th Congress APSN – Hong Kong

1997 7th Congress APSN – Sydney, Australia

2000 8th Congress APSN – Taipei, Taiwan

2003 9th Congress APSN – Pattaya, Thailand

2005 10th Congress APSN – Singapore

2008 11th Congress APSN – Kuala Lumpur, Malaysia

2010 12th Congress APSN – Seoul, Korea

2014 14th Congress APSN – Tokyo, Japan

2016 15th Congress APSN – Perth, Australia

2018 16th Congress APSN – Beijing, China